Clinical Trials Logo

Clinical Trial Summary

Perforated diverticulitis of the colon can be complicated by peritonitis, either purulent or fecal. Both are life threatening conditions requiring emergency surgery. The background in terms of reasons for inflammation (diverticulitis) and perforation to develop is unknown. In this study we focus on specific changes associated with inflammation, both in tissues and of fecal and mucosal microbiota.


Clinical Trial Description

A prospective study of abdominal fluid, periferal blood, tissues as well as feces in Patients (perforated diverticulitis with peritonitis undergoing emergency surgery, Group I), and in Controls (patients operated due to colorectal cancer, Group II; patients with mild diverticulitis not needing surgery, Group III). Immune acitvity in abdominal fluid and periferal blood by immunoassay of 92 individual proteins. mRNA expression of 96 specific genes in tissue samples. Quatification of bacterial diversity in feces and colon mucosa. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04427891
Study type Observational
Source Sahlgrenska University Hospital, Sweden
Contact Eva Haglind, MD, PhD
Phone +46705349088
Email eva.haglind@vgregion.se
Status Recruiting
Phase
Start date September 21, 2021
Completion date December 2026

See also
  Status Clinical Trial Phase
Recruiting NCT04220840 - The Damage Control Strategy for the Treatment of Perforated Diverticulitis of the Sigmoid Colon With Diffuse Peritonitis
Recruiting NCT01317485 - Laparoscopic Peritoneal Lavage or Resection for Generalised Peritonitis for Perforated Diverticulitis Phase 3
Completed NCT03332550 - A National Study of Clinical Results After Emergency Operation for Perforated Diverticulitis